<p>(<b>a</b>) Spleens from mice in each treatment group were stained to determine CD3<sup>+</sup>/CD8<sup>+</sup> and CD3<sup>+</sup>/CD25<sup>+</sup> numbers. Groups were as follows (i) tumour fed but no antibody depletion; (ii) PBS fed and no antibody depletion; (iii) PBS fed and anti-CD25 treated and (iv) tumour fed, anti-CD25 treated. CD8<sup>+</sup> and CD25<sup>+</sup> were examined from within the CD3<sup>+</sup> population. Each experiment was performed in triplicate; (<b>b</b>) Graph representing the changes in Teff numbers following tumour feeding and Ab depletions. Cumulative data from dot plots represented in (<b>a</b>) (n = 3).</p
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>(A and B) WT and CD3epsilon<sup>−/−</sup> mice were analyzed 14 days after tumor transplant. Sple...
<p><b>A, B</b>) B6 mice were injected with MCA-205-OVA tumor cells and tumors were excised and diges...
<p>Immune cells in the spleen were analyzed after tumor bearing C57BL/6 mice were treated with salin...
<p>(<b>a</b>) Dot plots show the number of peripheral blood Tregs in PBS (i–iv) or JBS (v-,viii) fed...
<p>(a) Representative plots of one animal per group for CD8 expression 20 days after tumor inoculati...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>Respectively on day 1, 3, 5, 7, 9 after treatment initiation in the independent treatment groups,...
<p>(A) (B) (C) Splenomegaly in tumor-bearing mice. (A) Spleens were collected and photographed at th...
<p>(<b>A</b>) Diagrammatic representation of the collection of specimens in early and advanced disea...
<p>MC38 colon tumor cells (2×10<sup>6</sup>) were implanted subcutaneously into female C57BL/6 mice....
<p>(<b>A</b>) Concentrations of various cytokines in ascites. A1, IL-6; A2, IL-12; A3, TNF-α; A4, IF...
<p>a) Freshly excised spleens from d24 4T1 tumor-bearing BALB/c mice left untreated (NT) or treated ...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. In separate experi...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>(A and B) WT and CD3epsilon<sup>−/−</sup> mice were analyzed 14 days after tumor transplant. Sple...
<p><b>A, B</b>) B6 mice were injected with MCA-205-OVA tumor cells and tumors were excised and diges...
<p>Immune cells in the spleen were analyzed after tumor bearing C57BL/6 mice were treated with salin...
<p>(<b>a</b>) Dot plots show the number of peripheral blood Tregs in PBS (i–iv) or JBS (v-,viii) fed...
<p>(a) Representative plots of one animal per group for CD8 expression 20 days after tumor inoculati...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, were treated as ind...
<p>Respectively on day 1, 3, 5, 7, 9 after treatment initiation in the independent treatment groups,...
<p>(A) (B) (C) Splenomegaly in tumor-bearing mice. (A) Spleens were collected and photographed at th...
<p>(<b>A</b>) Diagrammatic representation of the collection of specimens in early and advanced disea...
<p>MC38 colon tumor cells (2×10<sup>6</sup>) were implanted subcutaneously into female C57BL/6 mice....
<p>(<b>A</b>) Concentrations of various cytokines in ascites. A1, IL-6; A2, IL-12; A3, TNF-α; A4, IF...
<p>a) Freshly excised spleens from d24 4T1 tumor-bearing BALB/c mice left untreated (NT) or treated ...
<p>C57BL/6 mice (n = 3 per group) were implanted with unilateral subcutaneous B16-F10 tumor cells. T...
<p>Mice were treated with SU5416 (25 mg/kg/day) or equivalent amounts of vehicle. In separate experi...
<p>A). At 12<sup>th</sup> day after tumor implantation and after one time VLP vaccination at day 3, ...
<p>(A and B) WT and CD3epsilon<sup>−/−</sup> mice were analyzed 14 days after tumor transplant. Sple...
<p><b>A, B</b>) B6 mice were injected with MCA-205-OVA tumor cells and tumors were excised and diges...